Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs34921812 | chr10:27582062 | T/C | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |
| TGCT | rs34983424 | chr10:27562763 | C/G | 6.98E-7 | 132 | 42.18 | 46.3 | 20.6 | KM Plot |
| TGCT | rs35000415 | chr7:128585616 | C/T | 2.01E-5 | 132 | 45.1 | 30.3 | 17.1 | KM Plot |
| TGCT | rs35023245 | chr7:128633243 | GT/G | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs35053986 | chr10:27579381 | G/A | 2.72E-12 | 128 | 42.18 | 45.83 | 20.6 | KM Plot |
| TGCT | rs35065646 | chr12:129291767 | GA/G | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |
| TGCT | rs35069256 | chr7:128669912 | T/TA | 1.75E-5 | 133 | 43.68 | 30.3 | 17.1 | KM Plot |
| TGCT | rs35091912 | chr3:172507788 | AT/A | 8.65E-5 | 128 | 42.1 | 37.53 | 47.38 | KM Plot |
| TGCT | rs35144535 | chr7:128721777 | A/G | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs35161927 | chr2:3486174 | CT/C | 2.43E-5 | 131 | 39.38 | 74.47 | 25.32 | KM Plot |
| TGCT | rs35188261 | chr7:128683539 | G/A | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs35197130 | chr4:47444818 | G/A | 0.00014 | 132 | 45.83 | 36.1 | 51.6 | KM Plot |
| TGCT | rs35234849 | chr7:128648953 | T/C | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs35243976 | chr3:172547079 | G/C | 7.57E-6 | 134 | 42.03 | 46.3 | 25.8 | KM Plot |
| TGCT | rs35274937 | chr8:103089669 | GA/G | 0.000113 | 132 | 42.27 | 36.1 | 48.45 | KM Plot |